Skip to main content

Table 1 General information of the study patients

From: Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease

 

Mean ± SD / Median (IQR) or N (%)

Age, years

59.9 ± 14.9

Male

43 (56.6%)

BMI, kg/m2

24.7 ± 3.7

Current smoker

20 (26.3%)

Etiology

 Diabetic kidney disease

22 (28.9%)

 Hypertensive nephropathy

6 (7.9%)

 Glomerulonephritis

18 (23.7%)

 Others

7 (9.2%)

 Undetermined

23 (30.3%)

Previous CVD

32 (42.1%)

 Myocardial infarction

3 (3.9%)

 Stroke

27 (35.5)

 Coronary heart disease

6 (7.9%)

 Atrial fibrillation

2 (2.6%)

eGFR, mL/min/1.73m2

41.4 ± 25.4

Hemoglobin, g/L

112.5 ± 22.5

Albumin, g/L

36.0 ± 6.9

Total cholesterol, mmol/L

5.18 ± 2.03

Triglycerides, mmol/L

1.89 ± 1.52

HDL-C, mmol/L

1.23 ± 0.46

LDL-C, mmol/L

3.06 ± 1.23

Calcium, mmol/L

2.17 ± 0.20

Phosphorus, mmol/L

1.17 ± 0.23

CRP, mg/L

1.1 (0.5 - 4.0)

Urine PCR, mg/mmol

246.8 (55.6 – 493.3)

CNP, pg/ml

790.8 ± 309.1

  1. Abbreviations: BMI Body mass index, CNP C-type natriuretic peptide, CRP C-reactive protein, CVD Cardiovascular disease, eGFR Estimated glomerular filtration rate, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, PCR Protein to creatinine ratio